X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.reuters.com/business/healthcare-pharmaceuticals/liquidia-files-litigation-challenging-regulatory-exclusivity-rivals-inhaled-drug-2024-08-22/
https://www.biospace.com/fda/liquida-misses-full-approval-for-pulmonary-hypertension-drug-as-competitor-retains-market-exclusivity
https://www.fiercepharma.com/pharma/fda-opts-tentative-approval-liquidias-dry-powder-pah-med-yutrepia-after-lengthy-court-saga
https://www.fiercepharma.com/pharma/fda-cleared-approve-liquidias-inhaled-pah-drug-rival-uniteds-tyvaso
https://liquidia.com/news-releases/news-release-details/liquidia-corporation-present-23rd-annual-needham-virtual
https://www.reuters.com/business/healthcare-pharmaceuticals/united-therapeutics-starts-litigation-with-fda-allowing-liquidias-drug-2024-02-21/
https://endpts.com/liquidia-and-united-therapeutics-could-bring-new-lung-indication-into-legal-saga/
https://www.liquidia.com/news-releases/news-release-details/liquidia-corporation-reports-full-year-2022-financial-results
https://www.liquidia.com/news-releases/news-release-details/liquidia-corporation-report-full-year-2022-financial-results
https://www.globenewswire.com/news-release/2022/12/05/2567822/0/en/Liquidia-Announces-Collaboration-to-Develop-a-New-Infusion-Pump-for-Subcutaneous-Delivery-of-Treprostinil-Injection-to-Treat-Pulmonary-Arterial-Hypertension-PAH.html
Market Place
Share 
